BioVex Announces Publication of Head and Neck Cancer Clinical Trial Results with OncoVEX GM-CSF in the Journal …
BioVex Announces Publication of Head and Neck Cancer Clinical Trial Results with OncoVEX GM-CSF in the Journal …
WOBURN, Mass. & OXFORD, England–(BUSINESS WIRE)–Clinical Cancer Research Publication
Read more on Business Wire
Categories: Breast Cancer Radiation Tags: Announces, BioVex, cancer, Clinical, GMCSF, Head, Journal, neck, OncoVEX, Publication, Results, Trial
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
BioVex Appoints Ex Roche Oncology Head, Kapil Dhingra, to the Board of Directors
WOBURN, Mass.—-BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and the prevention of infectious disease, announced today that it has appointed Dr Kapil Dhingra to the Board of Directors as a Non-Executive.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Tumor Tags: Appoints, BioVex, board, Dhingra, Directors, Head, Kapil, Oncology, Roche
BioVex Initiates Phase 1 Clinical Trial with Its Genital Herpes Vaccine, ImmunoVEXHSV2
BioVex Initiates Phase 1 Clinical Trial with Its Genital Herpes Vaccine, ImmunoVEXHSV2
WOBURN, Mass.—-BioVex Inc, a private biotechnology company developing new generation biologics for the treatment of cancer and prevention of infectious disease, announced today that the first subject had been dosed in the Phase 1 study of its live attenuated genital herpes vaccine, ImmunoVEXHSV2.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Symptoms Tags: BioVex, Clinical, Genital, Herpes, ImmunoVEXHSV2, Initiates, Phase, Trial, vaccine